116308-39-5

Basic information

• Product Name: 2-<4-(1-piperazinyl)phenyl>ethyl alcohol
• Synonyms: 2-<4-(1-piperazinyl)phenyl>ethyl alcohol
• CAS NO: 116308-39-5
• Molecular Weight: 206.288
• Mol File: 116308-39-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-<4-(1-piperazinyl)phenyl>ethyl alcohol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-<4-(1-piperazinyl)phenyl>ethyl alcohol(116308-39-5)
• EPA Substance Registry System: 2-<4-(1-piperazinyl)phenyl>ethyl alcohol(116308-39-5)

Safety Data

• Hazardous Substances Data: 116308-39-5(Hazardous Substances Data)

Upstream product

• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 104-10-9 2-(4'-aminophenyl)ethyl alcohol 
• 71-36-3 butan-1-ol 

Downstream Products

• 126202-70-8 2-<4-<4-(4,4'-difluorobenzhydryl)-1-piperazinyl>phenyl>ethyl alcohol 
• 116308-40-8 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl alcohol 
• 116308-41-9 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl acetoacetate 
• 134364-85-5 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl 2-(4-cyano-2-pyridylmethylidene)acetoacetate 
• 133743-70-1 2-[1-(3-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 2-[4-(4-benzhydryl-piperazin-1-yl)-phenyl]-ethyl ester 
• 116308-51-1 2-<4-(4-benzhydryl-1-piperazinyl)phenyl>ethyl methyl 4-(4-cyano-2-pyridyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylate 
• 116308-53-3 2',6'-Dimethyl-2-trifluoromethyl-1',4'-dihydro-[3,4']bipyridinyl-3',5'-dicarboxylic acid 5'-{2-[4-(4-benzhydryl-piperazin-1-yl)-phenyl]-ethyl} ester 3'-methyl ester 
• 126202-59-3 2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-[2-(4-{4-[bis-(4-fluoro-phenyl)-methyl]-piperazin-1-yl}-phenyl)-ethyl] ester 5-methyl ester 
• 116308-56-6 AE₀₀₄₇ 

Relevant articles and documents

Compound and its as L-type calcium channel blocker or/and application of acetylcholine esterase inhibitors

Disclosed in this invention are compounds and the uses as L-type calcium channel blocker and/or acetylcholinesterase inhibitor thereof. The uses of said compounds in the manufactures of a medicament for the treatment of cardiovascular diseases, apoplexy or senile dementia are also disclosed in the present invention.

Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders

A cerebral hyperkinemic composition which containa as an effective ingredient at least a dihydropyridine derivative of the general formula wherein R1, R2 and R3, which are identical or different, independently represent an alkyl, a cycloalkyl or an

DIHYDROPYRIDINE DERIVATIVES AND PHARMACEUTICALS COMPOSITION THEREOF

Dihydropyridine derivatives of the formula wherein R1, R2, R3, R4, R5, A, B are defined as in the specification and nontoxic acid-addition salts thereof, have an excellent calcium blocking action (Ca-antagonist), and antihypertensive action, a platelet aggregation inhibiting action, a phosphodiesterase-inhibiting action and the like, and thus are useful as a medicine, such as a coronary vasocilator, a cerebral hyperkinemic, antihypertensive, thrombosis-preventing or treating agents, phosphodiesterase inhibitor or the like. Pharmaceutical compositions and methods of use are also disclosed